Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation

This study is ongoing, but not recruiting participants.

Study NCT00383994 Information provided by M.D. Anderson Cancer Center

First Received: October 2, 2006 Last Updated: September 1, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	September 2012 (Final data collection date for primary outcome measure)